Product Information
AZITHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.2384 per ML under NDC 70436022849. Its NADAC has been published 81 times since Nov 6, 2024.
FDA first approved this application on Jul 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/5mL
Manufacturer
Slate Run Pharmaceuticals LLCNDC
70436022849
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217036FDA Approved
7/27/2023
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has been published 81 times since Nov 6, 2024, and over the history we have for it it has declined 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2384 per ML |
|---|---|
| All-time high | $0.2580 (Jan 14, 2026) |
| All-time low | $0.1988 (Nov 20, 2024) |
| 52-week high | $0.2580 |
| 52-week low | $0.2231 |
| Median price | $0.2465 |
| Average price | $0.2395 |
| Largest weekly change | -19.3% (Nov 20, 2024) |
| Weeks tracked | 81 |
| Tracking since | Nov 6, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
+4.3%
1Y
-4.0%
3Y
N/A
5Y
N/A
All
-3.3%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 200 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 200 MG/5 ML SUSP, manufactured by Slate Run Pharmaceuticals LLC, is $0.2384 per ML (NDC 70436022849), effective May 20, 2026.
How has the price of AZITHROMYCIN 200 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has declined 3.3%. It has been tracked across 81 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 200 MG/5 ML SUSP?
Since Nov 6, 2024, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.1988 (Nov 20, 2024) to a high of $0.2580 (Jan 14, 2026), with a median of $0.2465 per ML.
Are there cheaper alternatives to AZITHROMYCIN 200 MG/5 ML SUSP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 200 MG/5 ML SUSP, is $0.2186 per ML — about 8% below AZITHROMYCIN 200 MG/5 ML SUSP.
Who manufactures AZITHROMYCIN 200 MG/5 ML SUSP?
AZITHROMYCIN 200 MG/5 ML SUSP (NDC 70436022849) is labeled by Slate Run Pharmaceuticals LLC, and CMS classifies it as a generic product.